Alcon Net Income 2019-2023 | ALC
Alcon annual/quarterly net income history and growth rate from 2019 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Alcon net income for the quarter ending December 31, 2023 was $0.427B, a 540.21% decline year-over-year.
- Alcon net income for the twelve months ending December 31, 2023 was $974M, a 190.75% increase year-over-year.
- Alcon annual net income for 2023 was $0.974B, a 190.75% increase from 2022.
- Alcon annual net income for 2022 was $0.335B, a 10.9% decline from 2021.
- Alcon annual net income for 2021 was $0.376B, a 170.81% decline from 2020.
| Alcon Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $974 |
| 2022 | $335 |
| 2021 | $376 |
| 2020 | $-531 |
| 2019 | $-656 |
| 2018 | $-227 |
| Alcon Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $427 |
| 2023-09-30 | $204 |
| 2023-06-30 | $169 |
| 2023-03-31 | $174 |
| 2022-12-31 | $-97 |
| 2022-09-30 | $116 |
| 2022-06-30 | $148 |
| 2022-03-31 | $168 |
| 2021-12-31 | $139 |
| 2021-09-30 | $2 |
| 2021-06-30 | $151 |
| 2021-03-31 | $84 |
| 2020-12-31 | $95 |
| 2020-09-30 | $-147 |
| 2020-06-30 | $-422 |
| 2020-03-31 | $-57 |
| 2019-12-31 | $-91 |
| 2019-09-30 | $-66 |
| 2019-06-30 | $-390 |
| 2019-03-31 | $-109 |
| 2018-12-31 | |
| 2018-09-30 | $-207 |
| 2018-06-30 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $38.876B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.237B | 26.44 |
| Intuitive Surgical (ISRG) | United States | $132.348B | 79.73 |
| DexCom (DXCM) | United States | $54.655B | 83.14 |
| Edwards Lifesciences (EW) | United States | $52.976B | 34.51 |
| IQVIA Holdings (IQV) | United States | $42.467B | 25.19 |
| IDEXX Laboratories (IDXX) | United States | $40.633B | 48.58 |
| STERIS (STE) | Ireland | $19.915B | 23.57 |
| Waters (WAT) | United States | $18.288B | 26.24 |
| Hologic (HOLX) | United States | $17.772B | 19.61 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.481B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.303B | 85.01 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.860B | 14.65 |
| Sysmex ADR (SSMXY) | Japan | $9.975B | 31.28 |
| Teleflex (TFX) | United States | $9.736B | 15.29 |
| Penumbra (PEN) | United States | $7.965B | 98.32 |
| Masimo (MASI) | United States | $7.156B | 40.13 |
| Globus Medical (GMED) | United States | $6.819B | 21.62 |
| Glaukos (GKOS) | United States | $5.024B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.724B | 22.50 |
| LivaNova (LIVN) | United Kingdom | $2.973B | 19.61 |
| TransMedics (TMDX) | United States | $2.920B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.687B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.570B | 17.63 |
| Nihon Kohden (NHNKY) | Japan | $2.380B | 20.13 |
| Tandem Diabetes Care (TNDM) | United States | $2.296B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.233B | 9.16 |
| Inari Medical (NARI) | United States | $2.207B | 380.70 |
| RxSight (RXST) | United States | $1.919B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.689B | 0.00 |
| Veracyte (VCYT) | United States | $1.462B | 0.00 |
| OPKO Health (OPK) | United States | $0.850B | 0.00 |
| Artivion (AORT) | United States | $0.835B | 96.52 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.825B | 15.26 |
| Paragon 28 (FNA) | United States | $0.744B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.712B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.691B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.636B | 0.00 |
| SiBone (SIBN) | United States | $0.586B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 18.65 |
| IRadimed (IRMD) | United States | $0.525B | 30.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
| Nevro (NVRO) | United States | $0.426B | 0.00 |
| NeuroPace (NPCE) | United States | $0.373B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.370B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
| CVRx (CVRX) | United States | $0.311B | 0.00 |
| AxoGen (AXGN) | United States | $0.285B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.275B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.182B | 9.81 |
| Alpha Tau Medical (DRTS) | Israel | $0.167B | 0.00 |
| Inogen (INGN) | United States | $0.153B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.144B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.134B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Neuronetics (STIM) | United States | $0.106B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.093B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 111.00 |
| Vasomedical (VASO) | United States | $0.052B | 9.33 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| DarioHealth (DRIO) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| LENSAR (LNSR) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |